未登录

L

Longding Liu

Chinese Academy of Medical Sciences and Peking Union Medical College

H指数:25

被引数:2,017

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ferritin-displayed engineered sCAR1 nanoparticles as a receptor-decoy antiviral strategy against Coxsackievirus B-associated inflammation

铁蛋白展示的工程化sCAR1纳米颗粒作为抗柯萨奇病毒B相关炎症的受体诱饵抗病毒策略

Antiviral Research

IF4

2026-10-270

PRE

A fusion ORF3a-E subgenomic RNA involved in SARS-CoV-2 infection efficacy by influencing cellular protein synthesis

一种融合的ORF3a-E亚基因组RNA，通过影响细胞蛋白质合成来参与SARS-CoV-2感染效率。

Frontiers in Immunology

IF5.9

2025-08-160

OA

Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals

单细胞分析揭示了NK细胞和单核细胞在控制疫苗接种者中SARS-CoV-2突破性感染中的作用

Human Vaccines & Immunotherapeutics

IF3.5

2025-07-290

OA

Essential role of CD56dimNKG2C+ NK cells trained by SARS-CoV-2 vaccines in protecting against COVID-19

CD56dimNKG2C+ NK细胞经SARS-CoV-2疫苗训练后对保护抗COVID-19发挥关键作用

Molecular Therapy

IF12

2025-05-300

OAAI

Pathologic Tissue Injury and Inflammation in Mice Immunized with Plasmid DNA-Encapsulated DOTAP-Based Lipid Nanoparticles

BIOCONJUGATE CHEMISTRY

IF3.9

2024-12-100

PRE

Apoptosis and pyroptosis in the nasal mucosa of Syrian hamster during SARS-CoV-2 infection and reinfection

IF8.1

2024-02-283

PRE

Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development

基于灭活SARS-CoV-2疫苗的异源加强预防接种增强体液免疫并促进BCR库发育

IF3.4

2024-01-241

OAAI

Risk Factors for Long COVID in Older Adults

老年人长期COVID的危险因素

IF3.9

2023-11-0811

OAAI

Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity

IF3.4

2023-02-234

OAAI

Influenza and Universal Vaccine Research in China

IF3.5

2022-12-3038

OAAI

Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells

IF3.4

2022-11-295

OAAI

Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection

SARS-CoV-2利用鼻粘膜进行再感染期间的复制和脱落

IF3.5

2022-07-232

OAAI

Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine

SARS-CoV-2 DNA疫苗与灭活疫苗联合给药的免疫学研究

IF3.4

2022-06-107

OAAI

Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques (vol 39, 110864, 2022)

IF6.9

2022-06-010

OAAI

Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques

IF6.9

2022-05-0110

OAAI

A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge

IF6.9

2021-12-0124

OAAI

Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models

EMERGING MICROBES & INFECTIONS

IF7.5

2021-11-219

OAAI

Role of CXCL5 in Regulating Chemotaxis of Innate and Adaptive Leukocytes in Infected Lungs Upon Pulmonary Influenza Infection

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-11-1821

OAAI

Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain

MICROBIOLOGY SPECTRUM

IF3.8

2021-10-3116

OAAI

Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys (vol 32, pg 1034, 2021)

BIOCONJUGATE CHEMISTRY

IF3.9

2021-09-090

OAAI